Martin Pulé
Founder en AUTOLUS THERAPEUTICS PLC .
Fortuna: 4 M $ al 31/03/2024
Perfil
Martin Pulé is the founder of Autolus Therapeutics Plc, where he currently holds the title of Chief Scientific Officer & Senior Vice President.
Autolus Therapeutics Plc was founded in 2014.
Dr. Pulé is also the founder of Autolus Ltd.
Dr. Pulé's education history includes an undergraduate degree from University College Dublin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
0.42% | 01/03/2023 | 698 741 ( 0.42% ) | 4 M $ | 31/03/2024 |
Cargos activos de Martin Pulé
| Empresas | Cargo | Inicio |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Founder | 01/09/2014 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Founder | - |
Formación de Martin Pulé.
| University College Dublin | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Martin Pulé
